BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20507943)

  • 1. Forging forward with 10 burning questions on FGF23 in kidney disease.
    Wolf M
    J Am Soc Nephrol; 2010 Sep; 21(9):1427-35. PubMed ID: 20507943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
    Gutiérrez OM
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
    Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF23 in chronic kidney disease.
    Wahl P; Wolf M
    Adv Exp Med Biol; 2012; 728():107-25. PubMed ID: 22396166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 23 and the future of phosphorus management.
    Wolf M
    Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):463-8. PubMed ID: 19770756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].
    Komaba H
    Clin Calcium; 2010 Jul; 20(7):1028-36. PubMed ID: 20585181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What would we like to know, and what do we not know about fibroblast growth factor 23?
    Cozzolino M; Galassi A; Apetrii M; Covic A
    J Nephrol; 2011; 24(6):696-706. PubMed ID: 21786227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast Growth Factor 23: A New Dimension to Diseases of Calcium-Phosphorus Metabolism.
    Hardcastle MR; Dittmer KE
    Vet Pathol; 2015 Sep; 52(5):770-84. PubMed ID: 26018436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
    Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
    Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.
    Hasegawa H; Nagano N; Urakawa I; Yamazaki Y; Iijima K; Fujita T; Yamashita T; Fukumoto S; Shimada T
    Kidney Int; 2010 Nov; 78(10):975-80. PubMed ID: 20844473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats.
    Nagano N; Miyata S; Abe M; Kobayashi N; Wakita S; Yamashita T; Wada M
    Kidney Int; 2006 Feb; 69(3):531-7. PubMed ID: 16395276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients.
    Gonzalez-Parra E; Gonzalez-Casaus ML; Galán A; Martinez-Calero A; Navas V; Rodriguez M; Ortiz A
    Nephrol Dial Transplant; 2011 Aug; 26(8):2567-71. PubMed ID: 21436379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [FGF23 in chronic kidney disease and kidney post-transplant patients].
    Negri A
    Nefrologia; 2009; 29(3):196-202. PubMed ID: 19554051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF23-parathyroid interaction: implications in chronic kidney disease.
    Komaba H; Fukagawa M
    Kidney Int; 2010 Feb; 77(4):292-8. PubMed ID: 20010546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
    Gutierrez O; Isakova T; Rhee E; Shah A; Holmes J; Collerone G; Jüppner H; Wolf M
    J Am Soc Nephrol; 2005 Jul; 16(7):2205-15. PubMed ID: 15917335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease.
    van Husen M; Fischer AK; Lehnhardt A; Klaassen I; Möller K; Müller-Wiefel DE; Kemper MJ
    Kidney Int; 2010 Jul; 78(2):200-6. PubMed ID: 20407479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia.
    Hassan A; Durlacher K; Silver J; Naveh-Many T; Levi R
    Am J Physiol Renal Physiol; 2016 Feb; 310(3):F217-21. PubMed ID: 26311115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.